Showing results (61-70 of 1,922) with videos related to

Sort By:
Pageof 193
Oncology (Williston Park, N.Y.)|April 1, 1997
An overview of adenocarcinoma of the small intestineA I Neugut, M R Marvin, V A Rella, et al.
Annals of Surgical Oncology|December 14, 2019
Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat SeriesJoshua C Leinwand, Robert N Taub, John A Chabot, et al.
World Journal of Surgery|December 11, 2019
Periadrenal Volume is a Better Predictor of Prolonged Operative Time in Laparoscopic Retroperitoneal Adrenalectomy than BMISarah S Pearlstein, Jennifer H Kuo, John A Chabot, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|February 14, 2009
Laparoscopic radical cholecystectomyAndrew A Gumbs, Luca Milone, Rula Geha, et al.
Nature|January 1, 1981
Orientation of oxygen in oxyhaemoproteins and its implications for haem catabolismS B Brown, A A Chabot, E A Enderby, et al.
Seminars in Oncology|January 12, 2019
Neoadjuvant Treatment for Pancreatic CancerAlexander G Raufi, Gulam A Manji, John A Chabot, et al.
The Journal of Surgical Research|January 1, 1996
The mechanism of UVB prevention of graft versus host diseaseJ I Greenfeld, J A Chabot, S F Oluwole, et al.
Surgery|September 14, 2019
A stepwise analysis of the diagnostic algorithm for the prediction of malignancy in thyroid nodulesBernice L Huang, John A Chabot, James A Lee, et al.
World Journal of Surgery|May 5, 2016
Septuagenarians and Older Patients are at a Higher Risk of Mortality with Adrenal Metastasectomy: An Analysis of the HCUP-NIS Database From 1992 to 2011Catherine McManus, Matthew Wingo, John A Chabot, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2010
Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trialsM D Kluger, R N Taub, M Hesdorffer, et al.
Pageof 193